Gillian A. Hotz, Ph.D., research professor of neurological surgery and director of the concussion program at the University of Miami Sports Medicine Institute, visited experts in Israel this month with some members of her multidisciplinary team leading a study on the effectiveness of cannabinoids in treating mild traumatic brain injury.
Recognizing the expertise, proven success record and promise of further discovery, the Leukemia & Lymphoma Society (LLS) has awarded a Specialized Center of Research (SCOR) grant to a 12-member team of researchers at Sylvester Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, and Brigham and Women’s Hospital. The team is led by Stephen D. Nimer, M.D., director of Sylvester.
The University of Miami and the Cambridge Innovation Center in Miami (CIC Miami) have partnered to establish South Florida’s first shared wet lab space for early stage biomedical startups. Years in the making, it is the final step in attracting and fostering biomedical discoveries in the South Florida region.
An international collaboration among researchers in Miami, New York, and Montreal aims to determine the best strategies for effectively providing people who inject drugs with pre-exposure prophylaxis (PrEP) to protect them from HIV infection. Their efforts will be backed by an $8 million grant just awarded from the National Institute on Drug Abuse.
New findings by researchers at Sylvester Comprehensive Cancer Center may prove to be an important solution to one of the more difficult problems faced in the field of precision medicine when it comes to treating cancer. An article reporting their findings, “Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies,” was published online November 9 by Scientific Reports.
Through an innovative outpatient antimicrobial stewardship program, the University of Miami Miller School of Medicine is taking action to manage antibiotics appropriately. “At least 30 percent of outpatient antibiotic prescriptions are unnecessary,” said Jose G. Castro, M.D., medical director of the University of Miami Medical Group Infection Control Department.
Peru’s former Minister of Health Patricia Jannet Garcia Funegra, M.D., M.P.H., Ph.D., Panamanian infectious disease specialist Nestor Sosa, M.D., and Brazilian oncologist Paulo M.G. Hoff, M.D., Ph.D., are three of the 464 Latin American and Caribbean physicians who have gained invaluable clinical and research knowledge in the past five decades through the William J. Harrington Medical Training Programs.
Artificial intelligence can help predict which patients with penetrating trauma are most likely to return with repeat injury in the future, a new study published online October 18 by JAMA Surgery reveals. Identifying people at higher risk could allow physicians to know when to take more aggressive preventive action.
The University of Miami’s Summer Scholars program gives high school sophomores and juniors the opportunity to experience college life and earn six college credits in a variety of academic areas, including health and medicine. The three-week program starts July 7, 2018. Students who apply by the early-action deadline of December 1, 2017 can receive half off the application fee with the special waiver code SSPDEC1.
A collaborative study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues has identified a novel therapeutic target for incurable prostate cancer. The research found a critical role for thioredoxin-1, a protein that protects cells from oxidative stress, in the progression of prostate cancer to the incurable castration-resistant stage.
Miami’s first transgender support group, Trans-Trend Miami, was started in early 2017 to offer a supportive environment for South Florida’s transgender community. This support group is a collaboration between the University of Miami Health System and The Hub at the LGBT Visitors Center in Miami Beach.
Researchers have discovered a way to extend how long clinicians have to reverse a stroke caused by a large clot blocking an artery in the brain. A new multicenter trial has shown that a combination of special brain imaging and reperfusion — restoration of blood flow — helps to identify stroke sufferers who can receive benefit for up to 24 hours.
With the telltale beating of a single drum and a tap on the shoulder with an iron arrow, members of the Iron Arrow Honor Society renewed one of the U’s greatest traditions during homecoming week. Marching across the Coral Gables and medical campuses in a solemn procession, they bestowed a leading University of Miami honor on 20 lucky recipients.
Linda Eads entered the Supervised Exercise Program offered by UHealth – the University of Miami Health System because “I had high cholesterol, my legs and hips hurt — and I hated to sweat.” Norman H. Altman, V.M.D., says, “I had an illness that caused neuropathy. After it was successfully treated, I realized I needed to get into a regular exercise program.” What they had in common was a lack of regular exercise.
Biomedical researchers often find it difficult to reproduce laboratory and clinical studies – a problem that raises costs, reduces the credibility of investigators and undermines the public trust in science, according to two University of Miami faculty members taking a fresh approach. Poorly written prose and software code are under-recognized contributors to failures to replicate other researcher's results, they say.
Angelique Muniz boxed in college, and since then she has kept physically active at a local gym, mixing cardio kickboxing with Zumba and yoga classes. But she fought the fight of her life two years ago, when an irritation in her throat turned out to be stage 3 oral cancer. Her aggressive cancer required an aggressive response: the removal and reconstruction of half of her tongue, followed by radiation and extensive therapy.
Pique Therapeutics, Inc. has announced encouraging results in a clinical trial of PT 107, an immunotherapy developed by a renowned scientist at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine to treat non-small cell lung cancer (NSCLC), the most common form of the disease.
There’s nothing magical about the number 5,000, Dr. Dipen Parekh says, but the fact that Sylvester Comprehensive Cancer Center and University of Miami Hospital recently exceeded that number of procedures with the breakthrough da Vinci Xi Surgical System “indicates very clearly for patients that they should have a very high level of confidence coming here for robotic surgeries because this is what we do day in and day out."
New signs on buildings across the University of Miami Health System (UHealth) herald the creation of a fully integrated academic health care system and a new name for all hospital-based facilities: University of Miami Hospital and Clinics. The change, which launched Sunday, October 29, after more than a year of preparation, is the first major step in the transformation of UHealth into a true single academic health center.
Wael El-Rifai, M.D., Ph.D., an internationally renowned physician-scientist, has joined the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine as co-leader of the Tumor Biology Program and associate director for Program Development. His departmental appointments are professor and associate vice chair of surgery, and professor of biochemistry and molecular biology.